Stocks in Motion: DRVW, IPIX, ENMD, STEM

OTCPro.com announces its list of stocks to watch! , , , , these stocks are looking to move!

Investors need to be watching DirectView, Inc, . DRVW was up over 25% yesterday with over 13 million shares changing hands. OTCPro.com believes the stock will continue to run and advises investors to keep a sharp eye on this issue. DRVW just had news out and serious investors and traders should look for an entry point. OTCPro.com believes the stock is under accumulation and poised for a major move.

DirectView, Inc. , a full-service provider of high-quality, cost efficient videoconferencing technologies and services, today announced they have executed a Letter of Intent to acquire Stratosphere Multimedia LLC.

Stratosphere Multimedia LLC is a visual communications company specializing in interactive meeting and event staging for VideoConferencing, Internet Broadcasting, and Satellite communications. Stratosphere maintains a pool of mobile videoconferencing and internet broadcasting systems, along with a global network database of 3,800 public videoconferencing suites and 1,700 hotel partners for multi-city events. Stratosphere possesses an expertise that brings mobility to videoconferencing combined with live and archived internet broadcasting. Stratosphere has been a leader in the industry in launching VCnetcast, http://www.VCnetcast.com, the first turnkey internet broadcasting interface that is fully compatible with all videoconferencing systems regardless of manufacturer.

Watch this stock; it could break out on the upside in the near term!

Other stocks moving are:

IPIX Corporation , a premium supplier of visual intelligence technologies, has announced its membership in GTSI Corp.'s InteGuard(TM) Physical Security Alliance. Additionally, IPIX also announced that it has selected GTSI to be its first government partner. The Alliance brings together more than 50 leading companies with recognized physical security products and services to develop a wide range of physical security protection system solutions for GTSI's customers.

EntreMed, Inc. , a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammation, today announced a published preclinical report supporting the use of 2-methoxyestradiol (2ME2) in combination with paclitaxel in the treatment of recurrent or advanced head and neck squamous cell carcinoma (HNSCC).

Stem Cells Inc. The stem-cell companies appeared to be bolstered by reports over the holiday weekend that New Jersey's acting governor, Richard Codey, has proposed spending $380 million on funding stem-cell research in his state. Codey has argued that New Jersey must spend the money so that it would not lose scientific talent to other states that are planning to offer lucrative funding for the emerging scientific field, such as California, Illinois and Wisconsin.

About OTCPro.com

OTCPro.com is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. OTCPros is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. OTCPro's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. OTCPro provides investors with a complete suite of online interactive financial data and tools that includes quotes, charts, company profiles, news, market commentary and SEC filings, just to name a few. OTCPros offers a free financial newsletter. To subscribe or get more information, visit our home page located at www.OTCPro.com.

OTCP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of an OTCP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an OTCP opinion, recommendation or analysis. Information regarding companies which OTCP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that OTCP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating OTCP's statements regarding a company. An affiliate of OTCP has been hired by NDE Group and Ken Shenkman for the publication and circulation of this report, and received from NDE one million free trading shares of common stock of DRVW and by Ken Shenkman two million free trading shares of common stock of DRVW for a total of three million shares. OTCP has also been promised an additional one million shares that have not yet been delivered and OTCP and affiliates have no other relationship to NDE or Ken Shenkman. This should be construed as a potential conflict of interest. OTCP's officers and directors reserve the right to buy additional shares of the company discussed in this opinion and may profit in the event those shares rise in value. When OTCP receives free trading shares as compensation for a profiled company, OTCP may sell part or all of any such shares during the period in which OTCP is performing such services.

Distributed by Market Wire